Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Eli Lilly to acquire AtaiBeckley for $6.75 per share

PRIVATEAug 28, 2026•about 3 hours ago

Acquiring Company

Eli Lilly and Company

Acquired Company

AtaiBeckley

IndianapolisUnited StatesBiotechnologyHealth CareMedicalBiotechnologyHealth CareTherapeutics

Description

Eli Lilly and Company has proposed to acquire AtaiBeckley Inc. for $6.75 per share in cash, along with potential additional payments tied to specific milestones. A legal investigation is underway to assess the adequacy of the proposed sale price. Shareholders of AtaiBeckley are urged to evaluate their rights regarding the transaction.

Company Information

Company

Eli Lilly and Company

Location

Indianapolis, Indiana, United States

About

Lilly is a medicine company turning science into healing to make life better for people around the world. They have been pioneering life-changing discoveries for nearly 150 years, and today their medicines help more than 51 million people across the globe. Lilly is focused on redefining diabetes care, treating obesity, advancing the fight against Alzheimer's disease, providing solutions to immune system disorders, and transforming difficult-to-treat cancers into manageable diseases. To learn more, visit Lilly.com and Lilly.com/news, or follow them on Facebook, Instagram and LinkedIn.

Don't miss Eli Lilly and Company's next move

Get an email the moment Eli Lilly and Company makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suresh
Senior decision-maker at this company
••••••••@••••••••

See Suresh's verified email →

Shafaat
Senior decision-maker at this company
••••••••@••••••••

See Shafaat's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Eli Lilly and Company's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired AtaiBeckley?

AtaiBeckley was acquired by Eli Lilly and Company, based in Indianapolis. The deal was reported on August 28, 2026. Lilly is a medicine company turning science into healing to make life better for people around the world. Eli Lilly and Company is privately held and operates in Biotechnology.

When did Eli Lilly and Company acquire AtaiBeckley?

Eli Lilly and Company's acquisition of AtaiBeckley was reported on August 28, 2026. Eli Lilly and Company has proposed to acquire AtaiBeckley Inc. for $6.75 per share in cash, along with potential additional payments tied to specific milestones. A legal investigation is underway to assess the adequacy of the proposed sale price. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does AtaiBeckley do?

AtaiBeckley Inc. is a biotechnology company based in Delaware, primarily focused on the development of novel therapeutics for mental health disorders. It is publicly traded (ATAI), operating in Biotechnology, and is based in United States.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.